ProjectHARMONY – A Double-blind, Placebo-controlled, Relapse Prevention Study of Pimavanserin for the Treatment of…
Basic data
Acronym:
HARMONY
Title:
A Double-blind, Placebo-controlled, Relapse Prevention Study of Pimavanserin for the Treatment of Hallucinations and Delusions Associated With Dementiarelated Psychosis
Duration:
01/03/2018 to 30/09/2020
Abstract / short description:
To evaluate relapse prevention in
subjects with dementia-related
psychosis treated with pimavanserin
compared to placebo
subjects with dementia-related
psychosis treated with pimavanserin
compared to placebo
Involved staff
Managers
Faculty of Medicine
University of Tübingen
University of Tübingen
Contact persons
Metzner, Marvin
Department of Psychiatry and Psychotherapy
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of General psychiatry and psychotherapy with outpatient clinic
Department of Psychiatry and Psychotherapy
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Funders
Nottingham, United Kingdom